Cargando…

Suppression of tumour-specific CD4(+) T cells by regulatory T cells is associated with progression of human colorectal cancer

BACKGROUND: There is indirect evidence that T cell responses can control the metastatic spread of colorectal cancer (CRC). However, an enrichment of CD4(+)Foxp3(+) regulatory T cells (Tregs) has also been documented. OBJECTIVE: To evaluate whether CRC promotes Treg activity and how this influences a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Betts, Gareth, Jones, Emma, Junaid, Syed, El-Shanawany, Tariq, Scurr, Martin, Mizen, Paul, Kumar, Mayur, Jones, Sion, Rees, Brian, Williams, Geraint, Gallimore, Awen, Godkin, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2011
Materias:	Colon
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388728/ https://www.ncbi.nlm.nih.gov/pubmed/22207629 http://dx.doi.org/10.1136/gutjnl-2011-300970

Ejemplares similares

T‐cell modulation by cyclophosphamide for tumour therapy
por: Hughes, Ellyn, et al.
Publicado: (2018)

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity
por: Simon, Anna Katharina, et al.
Publicado: (2007)

CD4(+)CD25(+)FOXP3(+) Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer
por: Clarke, Sarah L., et al.
Publicado: (2006)

Home Sweet Home: The Tumor Microenvironment as a Haven for Regulatory T Cells
por: Ondondo, Beatrice, et al.
Publicado: (2013)

Hunting for clues: Regulatory T cells and colorectal cancer
por: Gallimore, Awen, et al.
Publicado: (2012)

High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression
por: Bento, Diana Costa, et al.
Publicado: (2015)

Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer
por: Amicarella, F, et al.
Publicado: (2017)

Assessing the Prognostic Value of Preoperative Carcinoembryonic Antigen-Specific T-Cell Responses in Colorectal Cancer
por: Scurr, Martin J., et al.
Publicado: (2015)

Prevention and treatment of colon cancer by peroral administration of HAMLET (human α-lactalbumin made lethal to tumour cells)
por: Puthia, Manoj, et al.
Publicado: (2014)

Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC)
por: Salvucci, Manuela, et al.
Publicado: (2022)

Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells
por: Thomson, Amanda, et al.
Publicado: (2021)

Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment
por: Wang, Feng, et al.
Publicado: (2022)

Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer
por: Ferrer-Mayorga, Gemma, et al.
Publicado: (2017)

Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines
por: Davis, Hayley, et al.
Publicado: (2014)

Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer
por: Xu, Lixia, et al.
Publicado: (2016)

Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4(+) T-cell immunity
por: Pembroke, Tom, et al.
Publicado: (2012)

Reply: Forkhead box P3-positive regulatory T cells in immune surveillance and cancer
por: Betts, G, et al.
Publicado: (2007)

T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes
por: Mennonna, Daniele, et al.
Publicado: (2017)

Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis
por: Li, Chuangen, et al.
Publicado: (2022)

Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation
por: Lourenço, Filipe C, et al.
Publicado: (2014)

MED12 is recurrently mutated in Middle Eastern colorectal cancer
por: Siraj, Abdul K, et al.
Publicado: (2018)

TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres
por: Jones, A M, et al.
Publicado: (2011)

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells
por: Mangiapane, Laura Rosa, et al.
Publicado: (2022)

CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells
por: Manic, Gwenola, et al.
Publicado: (2018)

Canonical Wnt signals combined with suppressed TGFβ/BMP pathways promote renewal of the native human colonic epithelium
por: Reynolds, Amy, et al.
Publicado: (2014)

A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS
por: Rosmarin, Dan, et al.
Publicado: (2015)

Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification
por: Kleeman, Sam O, et al.
Publicado: (2020)

Long-term colorectal cancer incidence after adenoma removal and the effects of surveillance on incidence: a multicentre, retrospective, cohort study
por: Cross, Amanda J, et al.
Publicado: (2020)

The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design
por: Besneux, Matthieu, et al.
Publicado: (2018)

Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study
por: Cross, Amanda J, et al.
Publicado: (2019)

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
por: Møller, Pål, et al.
Publicado: (2017)

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
por: Møller, Pål, et al.
Publicado: (2017)

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
por: Møller, Pål, et al.
Publicado: (2018)

Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer
por: Corry, Shania M, et al.
Publicado: (2022)

Performance measures in three rounds of the English bowel cancer screening pilot
por: Moss, S M, et al.
Publicado: (2011)

Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population
por: Cui, R, et al.
Publicado: (2011)

Colorectal cancer screening with odour material by canine scent detection
por: Sonoda, Hideto, et al.
Publicado: (2011)

A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction
por: Tian, Sun, et al.
Publicado: (2013)

Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models
por: Hackl, Christina, et al.
Publicado: (2013)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_adfrba37o8g4gl2gl18dmnmcfb